Entheon Biomedical Corp | A NEW DIMENSION IN ADDICTION TREATMENT

Entheon Biomedical Corp | A NEW DIMENSION IN ADDICTION TREATMENT

ENTHEON IS IN A UNIQUE POSITION TO CHALLENGE THE NARRATIVE – AND EXPECTATIONS – AROUND ADDICTION RECOVERY.
Leveraging emerging bio-technology, we are pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorder. Focusing primarily on the powerful DMT molecule, Entheon exists to invert the addiction recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception.

Ticker:
CSE: ENBI
US: ENTBF

This video was conducted on behalf of Entheon Biomedical, and was funded by Gold Standard Media LLC and/or affiliates. For our full disclaimer, please visit:

DISCLAIMER: I do not provide personal investment advice and I am not a qualified licensed investment adviser. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read and/or view.

[Gman-]

Thanks Gerry for your video! Watched and liked

[wernerschonenberger]

Hi Geri! Great video, thanks for bringing the stock to our attention. Great idea ... but, the sad truth of pharmaceuticals is that it takes quite some money to "push" no substances thru the clinical trials for approval by FDA or EMA (European FDA counterpart). Is Entheon up to this task or (more likely) is there one of the big players (Pfizer, MSD, Sanofi, N8vartis, Glaxo Smith Kline, ...) interested to "help" or aquire the company?